217 related articles for article (PubMed ID: 10836334)
1. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome.
Grasemann H; Gärtig SS; Wiesemann HG; Teschler H; Konietzko N; Ratjen F
Eur Respir J; 1999 Jan; 13(1):114-8. PubMed ID: 10836334
[TBL] [Abstract][Full Text] [Related]
2. Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma.
Walker WT; Liew A; Harris A; Cole J; Lucas JS
Respir Med; 2013 Mar; 107(3):380-6. PubMed ID: 23290188
[TBL] [Abstract][Full Text] [Related]
3. The effect of l-Arginine on Ciliary Beat Frequency in PCD patients, non-PCD respiratory patients and healthy controls.
Kouis P; Hadjisavvas A; Middleton N; Papatheodorou SI; Kyriacou K; Yiallouros PK
Pulm Pharmacol Ther; 2018 Feb; 48():15-21. PubMed ID: 29056509
[TBL] [Abstract][Full Text] [Related]
4. Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children.
Güney E; Emiralioğlu N; Cinel G; Yalçın E; Doğru D; Kiper N; Özçelik HU
Turk J Pediatr; 2019; 61(1):20-25. PubMed ID: 31559717
[TBL] [Abstract][Full Text] [Related]
5. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.
Grasemann H; Kurtz F; Ratjen F
Am J Respir Crit Care Med; 2006 Jul; 174(2):208-12. PubMed ID: 16627863
[TBL] [Abstract][Full Text] [Related]
6. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia.
Karadag B; James AJ; Gültekin E; Wilson NM; Bush A
Eur Respir J; 1999 Jun; 13(6):1402-5. PubMed ID: 10445619
[TBL] [Abstract][Full Text] [Related]
7. Measurement of nasal nitric oxide by hand-held and stationary devices.
Montella S; Alving K; Maniscalco M; Sofia M; De Stefano S; Raia V; Santamaria F
Eur J Clin Invest; 2011 Oct; 41(10):1063-70. PubMed ID: 21413977
[TBL] [Abstract][Full Text] [Related]
8. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia.
Horváth I; Loukides S; Wodehouse T; Csiszér E; Cole PJ; Kharitonov SA; Barnes PJ
Thorax; 2003 Jan; 58(1):68-72. PubMed ID: 12511725
[TBL] [Abstract][Full Text] [Related]
9. Fitness and lung function in children with primary ciliary dyskinesia and cystic fibrosis.
Ring AM; Buchvald FF; Holgersen MG; Green K; Nielsen KG
Respir Med; 2018 Jun; 139():79-85. PubMed ID: 29858006
[TBL] [Abstract][Full Text] [Related]
10. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia.
Wodehouse T; Kharitonov SA; Mackay IS; Barnes PJ; Wilson R; Cole PJ
Eur Respir J; 2003 Jan; 21(1):43-7. PubMed ID: 12570107
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma.
Rollet-Cohen V; Bourderioux M; Lipecka J; Chhuon C; Jung VA; Mesbahi M; Nguyen-Khoa T; Guérin-Pfyffer S; Schmitt A; Edelman A; Sermet-Gaudelus I; Guerrera IC
J Proteomics; 2018 Aug; 185():1-7. PubMed ID: 30032860
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia.
Mateos-Corral D; Coombs R; Grasemann H; Ratjen F; Dell SD
J Pediatr; 2011 Sep; 159(3):420-4. PubMed ID: 21514598
[TBL] [Abstract][Full Text] [Related]
13. A novel, noninvasive assay shows that distal airway oxygen tension is low in cystic fibrosis, but not in primary ciliary dyskinesia.
Mendelsohn L; Wijers C; Gupta R; Marozkina N; Li C; Gaston B
Pediatr Pulmonol; 2019 Jan; 54(1):27-32. PubMed ID: 30485726
[TBL] [Abstract][Full Text] [Related]
14. Nasal and exhaled nitric oxide is reduced in adult patients with cystic fibrosis and does not correlate with cystic fibrosis genotype.
Thomas SR; Kharitonov SA; Scott SF; Hodson ME; Barnes PJ
Chest; 2000 Apr; 117(4):1085-9. PubMed ID: 10767244
[TBL] [Abstract][Full Text] [Related]
15. Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases.
Cockx M; Gouwy M; Van Damme J; Struyf S
Cell Mol Immunol; 2018 Apr; 15(4):312-323. PubMed ID: 29176750
[TBL] [Abstract][Full Text] [Related]
16. Do pulmonary and extrapulmonary features differ among cystic fibrosis, primary ciliary dyskinesia, and healthy children?
Denizoglu Kulli H; Gurses HN; Zeren M; Ucgun H; Cakir E
Pediatr Pulmonol; 2020 Nov; 55(11):3067-3073. PubMed ID: 32877003
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.
Grasemann H; Al-Saleh S; Scott JA; Shehnaz D; Mehl A; Amin R; Rafii M; Pencharz P; Belik J; Ratjen F
Am J Respir Crit Care Med; 2011 May; 183(10):1363-8. PubMed ID: 21278301
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients.
Grasemann C; Ratjen F; Schnabel D; Reutershahn E; Vester U; Grasemann H
Eur Respir J; 2008 Apr; 31(4):815-21. PubMed ID: 18094013
[TBL] [Abstract][Full Text] [Related]
19. Nasal nitric oxide.
Lefevere L; Willems T; Lindberg S; Jorissen M
Acta Otorhinolaryngol Belg; 2000; 54(3):271-80. PubMed ID: 11082762
[TBL] [Abstract][Full Text] [Related]
20. Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia.
Paff T; van der Schee MP; Daniels JM; Pals G; Postmus PE; Sterk PJ; Haarman EG
J Cyst Fibros; 2013 Sep; 12(5):454-60. PubMed ID: 23361110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
